Stansberry Asset Management’s Eli Lilly LLY Stock Holding History

Stansberry Asset Management’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$19.7M	Sell	21,424 -9	-0%	-$9.12K	2.03%	9
2025 Q4	$23M	Buy	21,433 +5,599	+35%	+$5.35M	2.33%	9
2025 Q3	$12.1M	Buy	15,834 +4,282	+37%	+$3.19M	1.26%	29
2025 Q2	$9.01M	Buy	11,552 +28	+0.2%	+$21.8K	0.98%	43
2025 Q1	$9.52M	Buy	11,524 +1,429	+14%	+$1.19M	1.14%	35
2024 Q4	$7.79M	Buy	10,095 +3,021	+43%	+$2.5M	1.01%	42
2024 Q3	$6.27M	Buy	7,074 +479	+7%	+$431K	0.78%	50
2024 Q2	$5.97M	Buy	6,595 +1,115	+20%	+$892K	0.78%	52
2024 Q1	$4.26M	Buy	5,480 +685	+14%	+$487K	0.58%	63
2023 Q4	$2.8M	Buy	+4,795	New	+$2.8M	0.46%	69

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Stansberry Asset Management's LLY Position: Q1 2026 in Review

Stansberry Asset Management reduced its Eli Lilly (LLY) stake by 0.04% in Q1 2026, selling an estimated $9.12K and leaving 21,424 shares worth $19.7M. The position accounts for 2.03% of the portfolio, ranked #9.

Stansberry Asset Management first reported a position in LLY in Q4 2023 and has held it in 10 quarters since. The position peaked at $23M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

Stansberry Asset Management held 21,424 shares of Eli Lilly worth $19.7M as of Q1 2026.
Stansberry Asset Management sold 9 Eli Lilly shares in Q1 2026, an estimated $9.12K.
Eli Lilly made up 2.03% of Stansberry Asset Management's portfolio in Q1 2026, its #9 holding.
Stansberry Asset Management first reported a position in Eli Lilly in Q4 2023 and has held it in 10 quarters since.
Stansberry Asset Management's Eli Lilly position peaked at $23M in Q4 2025.
4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Stansberry Asset Management's 13F filing for Q1 2026, filed 15 May 2026.